文献速递乳腺癌放疗放疗物理与技术

全自动容积旋转调强放疗技术用于局部晚期乳腺癌放射治疗

Fully automated volumetric modulated arc therapy technique for radiation therapy of locally advanced breast cancer.
PubMed 文献 · Radiat Oncol · 2023-10-30

本研究纳入25例术后接受螺旋断层放疗的局部晚期乳腺癌患者,比较自动生成容积旋转调强放疗计划(AP-VMAT)与手动临床螺旋断层放疗(HT)计划的剂量学参数及计划/实施时间。结果显示AP-VMAT在多数危及器官平均剂量上优于HT,PTV覆盖相似或更优,实施时间从HT的17±8分钟降至AP-VMAT的3±1分钟,计划时间从约6小时降至约2分钟。

要点

  • AP-VMAT计划在多数危及器官平均剂量上较HT计划有统计学显著改善,但心脏和同侧肺除外。
  • PTV乳腺/胸壁和PTV III-IV淋巴结的V95%无显著差异,PTV内乳淋巴结的V95%在AP-VMAT中更高。
  • HT计划在乳腺/胸壁和III-IV淋巴结的PTV V105%更小,实施时间17±8分钟,AP-VMAT为3±1分钟。

核心结论

  • AP-VMAT计划与临床HT计划相比质量相似或更优,mCycle实现了局部晚期乳腺癌VMAT治疗计划流程的自动化,显著减少工作量。

研究设计与样本

  • 研究纳入25例术后接受HT放疗的局部晚期乳腺癌患者,靶区包括左右乳腺/胸壁及III-IV淋巴结,伴或不伴内乳淋巴结和同步整合推量。
  • PTV由CTV外放5 mm等距获得,并从皮肤回缩5 mm,比较剂量学参数及实施/计划时间,并对AP-VMAT计划进行剂量验证。

主要发现

  • AP-VMAT计划在危及器官平均剂量上较HT计划有统计学显著改善,但心脏和同侧肺除外。
  • PTV乳腺/胸壁和PTV III-IV的V95%无显著差异,PTV内乳淋巴结的V95%在AP-VMAT计划中更高。
  • HT计划在乳腺/胸壁和III-IV的PTV V105%更小,PTV内乳淋巴结和推量区无差异。
  • HT平均实施时间为17±8分钟,AP-VMAT为3±1分钟;AP-VMAT计划平均γ通过率为97%±1%。
  • 计划时间从HT平均6小时缩短至AP-VMAT约2分钟。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to evaluate an a-priori multicriteria plan optimization algorithm (mCycle) for locally advanced breast cancer radiation therapy (RT) by comparing automatically generated VMAT (Volumetric Modulated Arc Therapy) plans (AP-VMAT) with manual clinical Helical Tomotherapy (HT) plans. METHODS: The study included 25 patients who received postoperative RT using HT. The patient cohort had diverse target selections, including both left and right breast/chest wall (CW) and III-IV node, with or without internal mammary node (IMN) and Simultaneous Integrated Boost (SIB). The Planning Target Volume (PTV) was obtained by applying a 5 mm isotropic expansion to the CTV (Clinical Target Volume), with a 5 mm clip from the skin. Comparisons of dosimetric parameters and delivery/planning times were conducted. Dosimetric verification of the AP-VMAT plans was performed. RESULTS: The study showed statistically significant improvements in AP-VMAT plans compared to HT for OARs (Organs At Risk) mean dose, except for the heart and ipsilateral lung. No significant differences in V95% were observed for PTV breast/CW and PTV III-IV, while increased coverage (higher V95%) was seen for PTV IMN in AP-VMAT plans. HT plans exhibited smaller values of PTV V105% for breast/CW and III-IV, with no differences in PTV IMN and boost. HT had an average (± standard deviation) delivery time of (17 ± 8) minutes, while AP-VMAT took (3 ± 1) minutes. The average γ passing rate for AP-VMAT plans was 97%±1%. Planning times reduced from an average of 6 h for HT to about 2 min for AP-VMAT. CONCLUSIONS: Comparing AP-VMAT plans with clinical HT plans showed similar or improved quality. The implementation of mCycle demonstrated successful automation of the planning process for VMAT treatment of locally advanced breast cancer, significantly reducing workload.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Marrazzo L, Redapi L, Pellegrini R, et al. Fully automated volumetric modulated arc therapy technique for radiation therapy of locally advanced breast cancer. Radiat Oncol. 2023. PMID: 37904150. doi:10.1186/s13014-023-02364-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。